New immunotherapy strategies for patients with sarcomas: highlights from the 2023 ASCO annual meeting

被引：4
作者：
Roulleaux-Dugage, Matthieu [2 ]
Italiano, Antoine [1 ,2 ,3 ]
机构：
[1] Inst Bergonie, Dept Med, 229 Cours Argonne, F-33000 Bordeaux, France
[2] Gustave Roussy, DITEP, Villejuif, France
[3] Univ Bordeaux, Fac Med, Bordeaux, France
来源：
JOURNAL OF HEMATOLOGY & ONCOLOGY | 2023年 / 16卷 / 01期
关键词：
OPEN-LABEL;
D O I：
10.1186/s13045-023-01486-6
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Immunotherapy has revolutionized cancer treatment, but currently, immuno-oncology agents have not been approved for patients with soft tissue sarcomas. However, there is growing evidence suggesting that immunotherapy could be an effective therapeutic strategy for this group of diseases. Here, we reviewed the latest advances of immunotherapy trials from the 2023 American Society of Clinical Oncology Annual Meeting, including some novel and encouraging combination regimens. Further research is still needed to fully understand the optimal use of these agents in sarcoma treatment.
引用
收藏
页数：5
相关论文
共 18 条
  • [1] Nivolumab with or without ipilimumab treatment for metastatic sarcoma (Alliance A091401): two open-label, non-comparative, randomised, phase 2 trials
    D'Angelo, Sandra P.
    Mahoney, Michelle R.
    Van Tine, Brian A.
    Atkins, James
    Milhem, Mohammed M.
    Jahagirdar, Balkrishna N.
    Antonescu, Cristina R.
    Horvath, Elise
    Tap, William D.
    Schwartz, Gary K.
    Streicher, Howard
    [J]. LANCET ONCOLOGY, 2018, 19 (03) : 416 - 426
  • [2] Combination of anthracyclines and anti-CD47 therapy inhibit invasive breast cancer growth while preventing cardiac toxicity by regulation of autophagy
    Feliz-Mosquea, Yismeilin R.
    Christensen, Ashley A.
    Wilson, Adam S.
    Westwood, Brian
    Varagic, Jasmina
    Melendez, Giselle C.
    Schwartz, Anthony L.
    Chen, Qing-Rong
    Griner, Lesley Mathews
    Guha, Rajarshi
    Thomas, Craig J.
    Ferrer, Marc
    Merino, Maria J.
    Cook, Katherine L.
    Roberts, David D.
    Soto-Pantoja, David R.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2018, 172 (01) : 69 - 82
  • [3] Role of Macrophage Targeting in the Antitumor Activity of Trabectedin
    Germano, Giovanni
    Frapolli, Roberta
    Belgiovine, Cristina
    Anselmo, Achille
    Pesce, Samantha
    Liguori, Manuela
    Erba, Eugenio
    Uboldi, Sarah
    Zucchetti, Massimo
    Pasqualini, Fabio
    Nebuloni, Manuela
    van Rooijen, Nico
    Mortarini, Roberta
    Beltrame, Luca
    Marchini, Sergio
    Nerini, Ilaria Fuso
    Sanfilippo, Roberta
    Casali, Paolo G.
    Pilotti, Silvana
    Galmarini, Carlos M.
    Anichini, Andrea
    Mantovani, Alberto
    D'Incalci, Maurizio
    Allavena, Paola
    [J]. CANCER CELL, 2013, 23 (02) : 249 - 262
  • [4] Grilley-Olson JE, 2023, J CLIN ONCOL, V41
  • [5] Pembrolizumab in soft-tissue sarcomas with tertiary lymphoid structures: a phase 2 PEMBROSARC trial cohort
    Italiano, A.
    Bessede, A.
    Pulido, M.
    Bompas, E.
    Piperno-Neumann, S.
    Chevreau, C.
    Penel, N.
    Bertucci, F.
    Toulmonde, M.
    Bellera, C.
    Guegan, J. P.
    Rey, C.
    Sautes-Fridman, C.
    Bougouin, A.
    Cantarel, C.
    Kind, M.
    Spalato, M.
    Dadone-Montaudie, B.
    Le Loarer, F.
    Blay, J. Y.
    Fridman, W. H.
    [J]. NATURE MEDICINE, 2022, 28 (06) : 1199 - +
  • [6] PD1/PD-L1 targeting in advanced soft-tissue sarcomas: a pooled analysis of phase II trials
    Italiano, Antoine
    Bellera, Carine
    D'Angelo, Sandra
    [J]. JOURNAL OF HEMATOLOGY & ONCOLOGY, 2020, 13 (01)
  • [7] Consensus guidelines for the detection of immunogenic cell death
    Kepp, Oliver
    Senovilla, Laura
    Vitale, Ilio
    Vacchelli, Erika
    Adjemian, Sandy
    Agostinis, Patrizia
    Apetoh, Lionel
    Aranda, Fernando
    Barnaba, Vincenzo
    Bloy, Norma
    Bracci, Laura
    Breckpot, Karine
    Brough, David
    Buque, Aitziber
    Castro, Maria G.
    Cirone, Mara
    Colombo, Maria I.
    Cremer, Isabelle
    Demaria, Sandra
    Dini, Luciana
    Eliopoulos, Aristides G.
    Faggioni, Alberto
    Formenti, Silvia C.
    Fucikova, Jitka
    Gabriele, Lucia
    Gaipl, Udo S.
    Galon, Jerome
    Garg, Abhishek
    Ghiringhelli, Francois
    Giese, Nathalia A.
    Guo, Zong Sheng
    Hemminki, Akseli
    Herrmann, Martin
    Hodge, James W.
    Holdenrieder, Stefan
    Honeychurch, Jamie
    Hu, Hong-Min
    Huang, Xing
    Illidge, Tim M.
    Kono, Koji
    Korbelik, Mladen
    Krysko, Dmitri V.
    Loi, Sherene
    Lowenstein, Pedro R.
    Lugli, Enrico
    Ma, Yuting
    Madeo, Frank
    Manfredi, Angelo A.
    Martins, Isabelle
    Mavilio, Domenico
    [J]. ONCOIMMUNOLOGY, 2014, 3 (09):
  • [8] Increased infiltration of M2-macrophages, T-cells and PD-L1 expression in high grade leiomyosarcomas supports immunotherapeutic strategies
    Kostine, Marie
    Briaire-de Bruijn, Inge H.
    Cleven, Arjen H. G.
    Vervat, Carly
    Corver, Willem E.
    Schilham, Marco W.
    Van Beelen, Els
    van Boven, Hester
    Haas, Rick L.
    Italiano, Antoine
    Cleton-Jansen, Anne-Marie
    Bovee, Judith V. M. G.
    [J]. ONCOIMMUNOLOGY, 2018, 7 (02):
  • [9] Martin Broto J, 2023, J CLIN ONCOL, V41, P11502
  • [10] Movva S, 2023, J CLIN ONCOL, V41, P11508
12